Algeria vs Bhutan: Cause of death, by non-communicable diseases, ages 0-4, female
Algeria
24.5%
in 2021
Bhutan
24.1%
in 2021
Algeria rank
113th
Bhutan rank
115th
Cause of death, by non-communicable diseases, ages 0-4, female over time
- Algeria
- Bhutan
How they compare
Algeria currently reports 24.5% against 24.1% in Bhutan, a difference of 0.4%.
Across all 6 years both countries report, Algeria has been ahead every year.
Algeria ranks 113th and Bhutan ranks 115th of 185 countries.
Algeria has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Algeria | Bhutan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 16.0% | 8.5% | 7.4% | Algeria |
| 2010s | 24.2% | 17.3% | 6.9% | Algeria |
| 2020s | 24.7% | 23.7% | 1.0% | Algeria |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 0-4, female, Algeria or Bhutan?
- Algeria, at 24.5% against 24.1% in Bhutan as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 0-4, female between Algeria and Bhutan?
- 0.4%, with Algeria ahead.
- How many years of comparable data are there for Algeria and Bhutan?
- 6 years are reported by both, from 2000 to 2021.
- How do Algeria and Bhutan rank globally for cause of death, by non-communicable diseases, ages 0-4, female?
- Algeria ranks 113th and Bhutan ranks 115th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 0-4, female (% of total female deaths ages 0-4). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 0-4 due to non-communicable diseases divided by number of all female deaths ages 0-4, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.